Benzoic acid derivatives exhibit anti-inflammatory, antioxidant, and antiplatelet properties
However, every skin is unique, and it's crucial to listen to your skin's needs
Severe or multisystem metabolic disease: Significant obesity plus diabetes, MASLD, OSA, or clustered cardiovascular risk factors, where every extra few percentage points of weight and risk reduction matter. Patients who need maximum, not moderate, change: Those aiming for 20%plus loss to qualify for surgery, offload joints, or defuse highstakes diagnoses in a defined time window. Patients who can handle tighter structure: People willing to tolerate stronger appetite suppression, closer titration, and more lab and nutrition oversight in exchange for bigger, faster shifts in body weight and cardiometabolic markers. Who leans toward semaglutide
The underlying mechanisms of cardiovascular and renal protection differ partially between GLP1-RAs (mainly anti-atherogenic and vascular effects) and SGLT2is (primarily systemic and intrarenal hemodynamic changes)
What's the difference between MASH and fatty liver
El-Laithy, H
